Literature DB >> 23440106

Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis.

Maurizio Cutolo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23440106     DOI： 10.1136/annrheumdis-2012-202538

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

Review 1.  [Regulatory T cells and rheumatic diseases].

Authors:  J Y Humrich; T Kamradt; G Riemekasten
Journal:  Z Rheumatol       Date:  2015-02       Impact factor: 1.372

2.  Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus.

Authors:  Kendra A Young; Melissa E Munroe; Joel M Guthridge; Diane L Kamen; Timothy B Niewold; Gary S Gilkeson; Michael H Weisman; Mariko L Ishimori; Jennifer Kelly; Patrick M Gaffney; Kathy H Sivils; Rufei Lu; Daniel J Wallace; David R Karp; John B Harley; Judith A James; Jill M Norris
Journal:  Ann Rheum Dis       Date:  2016-06-09       Impact factor: 19.103

Review 3.  Immunotherapies for Immune-Mediated Myopathies: A Current Perspective.

Authors:  Merrilee Needham; Frank L Mastaglia
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

4.  1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption.

Authors:  Peter Oelzner; Peter K Petrow; Gunter Wolf; Rolf Bräuer
Journal:  BMC Musculoskelet Disord       Date:  2014-10-14       Impact factor: 2.362

5.  Effects of 1,25-dihydroxyvitamin D3 on IL-17/IL-23 axis, IFN-γ and IL-4 expression in systemic lupus erythematosus induced mice model.

Authors:  Fatemeh Faraji; Maryam Rastin; Fahimeh Lavi Arab; Mohammad Reza Kalantari; Shahrzad Zamani Taghizadeh Rabe; Nafise Tabasi; Mahmoud Mahmoudi
Journal:  Iran J Basic Med Sci       Date:  2016-04       Impact factor: 2.699

6.  Skin Involvement and Pulmonary Hypertension Are Associated with Vitamin D Insufficiency in Scleroderma.

Authors:  Marco Atteritano; Domenico Santoro; Giorgio Corallo; Elisa Visalli; Michele Buemi; Antonino Catalano; Antonino Lasco; Alessandra Bitto; Francesco Squadrito
Journal:  Int J Mol Sci       Date:  2016-12-14       Impact factor: 5.923

Review 7.  Shared and distinct mechanisms of fibrosis.

Authors:  Jörg H W Distler; Andrea-Hermina Györfi; Meera Ramanujam; Michael L Whitfield; Melanie Königshoff; Robert Lafyatis
Journal:  Nat Rev Rheumatol       Date:  2019-11-11       Impact factor: 20.543

8.  Vitamin D Deficiency in Egyptian Systemic Lupus Erythematosus Patients: How Prevalent and Does It Impact Disease Activity?

Authors:  Nouran M Abaza; Reem M El-Mallah; Asmaa Shaaban; Sameh A Mobasher; Khaled F Al-Hassanein; Amr A Abdel Zaher; Rania H El-Kabarity
Journal:  Integr Med Insights       Date:  2016-09-26

9.  Altered microRNAs expression in T cells of patients with SLE involved in the lack of vitamin D.

Authors:  Dao-Jun Chen; Lan-Ju Li; Xiao-Ke Yang; Tao Yu; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Oncotarget       Date:  2017-07-07

Review 10.  Vitamin D levels in systemic sclerosis patients: a meta-analysis.

Authors:  Lin An; Ming-Hui Sun; Feng Chen; Jin-Ran Li
Journal:  Drug Des Devel Ther       Date:  2017-10-27       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.